A drug with the SMILES CS(=O)(=O)c1ccc2nc(NC(=O)c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3)sc2c1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -3.357%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CS(=O)(=O)c1ccc2nc(NC(=O)c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3)sc2c1
CS(=O)(=O)c1ccc2nc(NC(=O)c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3)sc2c1
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-3,5-dinitrobenzamide